Peptides for Fat Loss Research
Fat-loss and adipose-model peptide research spans three families: incretin/GLP analogs, amylin analogs, and lipolytic fragments. Ares carries the full range in USA-synthesized, HPLC-verified vials.
Mechanism & research context
GLP-1, GLP-3RT (retatrutide), and survodutide act on incretin and glucagon receptors in metabolic models. Cagrilintide is an amylin analog frequently studied alongside semaglutide. AOD-9604 and HGH Fragment 176-191 are lipolytic peptide fragments; tesofensine is a triple monoamine reuptake inhibitor studied in appetite-regulation research.
Referenced compounds
Advanced metabolic research compound. Studied in metabolic and energy pathway models. High-purity research-grade material.
Long-acting amylin analog studied in metabolic research.
Dual research blend of long-acting amylin and GLP-1 analogs examined in metabolic research models.
Modified peptide fragment investigated in lipid metabolism research.
Triple monoamine reuptake inhibitor studied in appetite-regulation and metabolic research models.
Synthetic C-terminal hGH fragment studied in lipolytic and adipose research models.
Research questions
- What is the difference between GLP-1 and GLP-3RT in research?
- GLP-1 is a single-receptor incretin analog; GLP-3RT (retatrutide) is a triple agonist acting on GLP-1, GIP, and glucagon receptors and is more frequently referenced in advanced metabolic-model literature.
- Is cagrilintide used alone or blended?
- Both — cagrilintide research is common as a monotherapy amylin analog and as a fixed-ratio blend with semaglutide.
All Ares Research Lab compounds are intended strictly for research and laboratory use only. Not for human consumption. Every lot ships with COA on request — HPLC purity, MS confirmation, and endotoxin data.